Pharmaceuticals

METHYLPYRROLIDONE USP-NF

Excipient developed for pharmaceutical formulations. It is used as a solvent in oral solid dosage forms. Benefits:Highly pureComplies with USP-NF specifications

METHYLPYRROLIDONE USP-NF/PH.EUR PARENTEX

Excipient developed for pharmaceutical applications. It is used as a solvent and co-solvent in injectable formulations. Benefits: Helps to maintain low level of endotoxins and metallic impuritiesComplies with USP-NF and Ph Eur specifications

METHYL SALICYLATE BP

Excipient developed for pharmaceutical applications.Benefits:Assay: 99.89 %Complies with BP specifications

MONOBASIC SODIUM PHOSPHATE ANHYDROUS USP

Excipient developed for pharmaceutical applications. It is used to adjust pH in solid and semi-solid dosage formulations.Benefits: Odorless, freely soluble in waterAssay: 99.8 %Complies with USP specifications

MONOBASIC SODIUM PHOSPHATE ANHYDROUS USP/BP PARENTEX PLUS

Excipient developed for pharmaceutical applications. It is used as a pH modifier and buffering agent in injectable formulations. Benefits:Odorless, with assay: 99.50 %Complies with USP and BP specificationsHelps to maintain low level of endotoxins and metallic impurities

MONOBASIC SODIUM PHOSPHATE MONOHYDRATE USP/BP

Excipient developed for pharmaceutical formulations.Benefits:Available in colorless crystals formSoluble in waterComplies with USP and BP specifications

MONOBASIC SODIUM PHOSPHATE MONOHYDRATE USP/BP PARENTEX PLUS

Excipient developed for injectable pharmaceutical formulations.Benefits:Available in colorless crystalsVery soluble in water, very slightly soluble in ethanol (96%)Assay: 98.6% (dried substance)Complies with BP and USP specifications

MONO SODIUM GLYCINE CARBONATE

Excipient developed for pharmaceutical formulations. It is used in para-effervescent tablets. Benefits: Freely soluble in waterMeets with USDMF requirements